The regulation of fibrosis in airway remodeling in asthma

Molecular and Cellular Endocrinology

Volumn 351, Issue 2, 2012, Pages 167-175

  Royce, Simon G ^a   Cheng, Victor ^a   Samuel, Chrishan S ^b   Tang, Mimi L K ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Airway remodeling; Asthma; Fibrosis; Relaxin; Therapy

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CGEN 25009; COLLAGEN; CR 002; CYTOKINE ANTIBODY; DEXAMETHASONE; FLUTICASONE PROPIONATE; FRESOLIMUMAB; GLUCOCORTICOID; HORMONE RECEPTOR; MATRIX METALLOPROTEINASE; OMALIZUMAB; ORNITHINE PHENYLACETATE; POLYPEPTIDE; PROTEIN RXFP1; PROTEIN RXFP2; RECOMBINANT PROTEIN; RELAXIN; SMAD2 PROTEIN; SMAD3 PROTEIN; THEOPHYLLINE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AIRWAY REMODELING; ALLERGIC ASTHMA; ALLERGIC REACTION; ASTHMA; BASEMENT MEMBRANE; COLLAGEN DEGRADATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MECHANISM; ENVIRONMENTAL FACTOR; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROGENESIS; FIBROSING ALVEOLITIS; HORMONE RESPONSIVE ELEMENT; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITY ADJUSTED LIFE YEAR; REVIEW;

AIRWAY REMODELING; ASTHMA; COLLAGEN; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; PULMONARY FIBROSIS; RELAXIN; RESPIRATORY SYSTEM; SMAD2 PROTEIN; SMAD3 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84857139903     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.01.007     Document Type: Review

References (74)

1. AIHW (Australian Centre for Asthma Monitoring), 2005. Asthma in Australia 2005, AIHW Asthma Series 2. AIHW Cat. No. ACM 6. AIHW, Canberra.
2. Aysola R.S., Hoffman E.A., Gierada D., Wenzel S., Cook-Granroth J., Tarsi J., Zheng J., Schechtman K.B., Ramkumar T.P., Cochran R., Xueping E., Christie C., Newell J., Fain S., Altes T.A., Castro M. Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology. Chest 2008, 134:1183-1191.
3. Barbato A., Turato G., Baraldo S., Bazzan E., Calabrese F., Panizzolo C., Zanin M.E., Zuin R., Maestrelli P., Fabbri L.M., Saetta M. Epithelial damage and angiogenesis in the airways of children with asthma. Am. J. Respir. Crit. Care Med. 2006, 174:975-981.
4. Barnes P.J. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Invest. 2008, 118:3546-3556.
5. Bathgate R.A., Ivell R., Sanborn B.M., Sherwood O.D., Summers R.J. Receptors for relaxin family peptides. Ann. NY Acad. Sci. 2005, 1041:61-76.
6. Bathgate R.A., Ivell R., Sanborn B.M., Sherwood O.D., Summers R.J. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev. 2006, 58:7-31.
7. Benayoun L., Druilhe A., Dombret M.C., Aubier M., Pretolani M. Airway structural alterations selectively associated with severe asthma. Am. J. Respir. Crit. Care Med. 2003, 167:1360-1368.
8. Bentley J.K., Hershenson M.B. Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration. Proc. Am. Thorac. Soc. 2008, 5:89-96.
9. Bisgaard H., Hermansen M.N., Loland L., Halkjaer L.B., Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N. Engl. J. Med. 2006, 354:1998-2005.
10. Borish L., Culp J.A. Asthma: a syndrome composed of heterogeneous diseases. Ann. Allergy Asthma Immunol. 2008, 101:1-8. (quiz 8-11, 50).
11. Bosse Y., Rola-Pleszczynski M. Controversy surrounding the increased expression of TGF beta 1 in asthma. Respir. Res. 2007, 8:66.
12. Boxall C., Holgate S.T., Davies D.E. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur. Respir. J. 2006, 27:208-229.
13. Broide D.H. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J. Allergy Clin. Immunol. 2008, 121:560-570. (quiz 571-2).
14. Camoretti-Mercado B., Solway J. Transforming growth factor-beta1 and disorders of the lung. Cell Biochem. Biophys. 2005, 43:131-148.
15. Davies D.E., Wicks J., Powell R.M., Puddicombe S.M., Holgate S.T. Airway remodeling in asthma: new insights. J. Allergy Clin. Immunol. 2003, 111:215-225. (quiz 226).
16. Donohue J.F. Safety and efficacy of beta agonists. Respir. Care 2008, 53:618-622. (discussion 623-4).
17. Dschietzig T., Bartsch C., Stangl V., Baumann G., Stangl K. Identification of the pregnancy hormone relaxin as glucocorticoid receptor agonist. FASEB J. 2004, 18:1536-1538.
18. Dschietzig T., Bartsch C., Greinwald M., Baumann G., Stangl K. The pregnancy hormone relaxin binds to and activates the human glucocorticoid receptor. Ann. NY Acad. Sci. 2005, 1041:256-271.
19. Dschietzig T., Bartsch C., Baumann G., Stangl K. RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway. Regul. Pept. 2009, 154:77-84.
20. Dschietzig T., Bartsch C., Wessler S., Baumann G., Stangl K. Autoregulation of human relaxin-2 gene expression critically involves relaxin and glucocorticoid receptor binding to glucocorticoid response half-sites in the relaxin-2 promoter. Regul. Pept. 2009, 155:163-173.
21. Fedorov I.A., Wilson S.J., Davies D.E., Holgate S.T. Epithelial stress and structural remodelling in childhood asthma. Thorax 2005, 60:389-394.
22. Ganguly K., Stoeger T., Wesselkamper S.C., Reinhard C., Sartor M.A., Medvedovic M., Tomlinson C.R., Bolle I., Mason J.M., Leikauf G.D., Schulz H. Candidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure. Physiol. Genomics 2007, 31:410-421.
23. Garibay-Tupas J.L., Okazaki K.J., Tashima L.S., Yamamoto S., Bryant-Greenwood G.D. Regulation of the human relaxin genes H1 and H2 by steroid hormones. Mol. Cell. Endocrinol. 2004, 219:115-125.
24. Guilbert T.W., Morgan W.J., Zeiger R.S., Mauger D.T., Boehmer S.J., Szefler S.J., Bacharier L.B., Lemanske R.F., Strunk R.C., Allen D.B., Bloomberg G.R., Heldt G., Krawiec M., Larsen G., Liu A.H., Chinchilli V.M., Sorkness C.A., Taussig L.M., Martinez F.D. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N. Engl. J. Med. 2006, 354:1985-1997.
25. Halls M.L., Bathgate R.A., Summers R.J. Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes. J. Pharmacol. Exp. Ther. 2007, 320:281-290.
26. Holgate S.T. Epithelial damage and response. Clin. Exp. Allergy 2000, 30(Suppl. 1):37-41.
27. Holgate S.T. Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 2007, 120:1233-1244. (quiz 1245-6).
28. Holgate S.T. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 2007, 28:248-251.
29. Holgate S.T. Pathogenesis of asthma. Clin. Exp. Allergy 2008, 38:872-897.
30. Holgate S.T. The airway epithelium is central to the pathogenesis of asthma. Allergol. Int. 2008, 57:1-10.
31. Holgate S.T., Holloway J., Wilson S., Bucchieri F., Puddicombe S., Davies D.E. Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. Proc. Am. Thorac. Soc. 2004, 1:93-98.
32. Hsu S.Y., Nakabayashi K., Nishi S., Kumagai J., Kudo M., Sherwood O.D., Hsueh A.J.W. Activation of orphan receptors by the hormone relaxin. Science 2002, 295:671-674. [see comment].
33. Huang X., Gai Y., Yang N., Lu B., Samuel C.S., Thannickal V.J., Zhou Y. Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am. J. Pathol. 2011, 179:2751-2765.
34. James A. Airway remodeling in asthma. Curr. Opin. Pulm. Med. 2005, 11:1-6.
35. Jeffery P.K. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 2001, 164:S28-S38.
36. Jeffery P.K., Laitinen A., Venge P. Biopsy markers of airway inflammation and remodelling. Respir. Med. 2000, 94(Suppl. F):S9-S15.
37. Kariyawasam H.H., Robinson D.S. The role of eosinophils in airway tissue remodelling in asthma. Curr. Opin. Immunol. 2007, 19:681-686.
38. Kumagai K., Ohno I., Okada S., Ohkawara Y., Suzuki K., Shinya T., Nagase H., Iwata K., Shirato K. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol. 1999, 162:4212-4219.
39. Lagente V., Manoury B., Nenan S., Le Quement C., Martin-Chouly C., Boichot E. Role of matrix metalloproteinases in the development of airway inflammation and remodeling. Braz. J. Med. Biol. Res. 2005, 38:1521-1530.
40. Le A.V., Cho J.Y., Miller M., McElwain S., Golgotiu K., Broide D.H. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J. Immunol. 2007, 178:7310-7316.
41. Masoli M., Fabian D., Holt S., Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004, 59:469-478.
42. Mauad T., Bel E.H., Sterk P.J. Asthma therapy and airway remodeling. J. Allergy Clin. Immunol. 2007, 120:997-1009. (quiz 1010-1).
43. McKenzie D.C., Boulet L.P. Asthma, outdoor air quality and the Olympic Games. CMAJ 2008, 179:543-548.
44. Moffatt M.F., Gut I.G., Demenais F., Strachan D.P., Bouzigon E., Heath S., von Mutius E., Farrall M., Lathrop M., Cookson W.O. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 2010, 363:1211-1221.
45. Mookerjee I., Solly N.R., Royce S.G., Tregear G.W., Samuel C.S., Tang M.L. Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease. Endocrinology 2006, 147:754-761.
46. Mookerjee I., Tang M.L.K., Solly N., Tregear G.W., Samuel C.S. Investigating the role of relaxin in the regulation of airway fibrosis in animal models of acute and chronic allergic airway disease. Ann. NY Acad. Sci. 2005, 1041:194-196.
47. Moore B., Murphy R.F., Agrawal D.K. Interaction of TGF-beta with immune cells in airway disease. Curr. Mol. Med. 2008, 8:427-436.
48. National Heart Lung and Blood Institute, 2007. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, NIH, Publication No. 07-4051.
49. Pascual R.M., Peters S.P. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J. Allergy Clin. Immunol. 2005, 116:477-486. (quiz 487).
50. Passalacqua G., Ciprandi G. Allergy and the lung. Clin. Exp. Immunol. 2008, 153(Suppl. 1):12-16.
51. Pei L. Identification of a negative glucocorticoid response element in the rat type 1 vasoactive intestinal polypeptide receptor gene. J. Biol. Chem. 1996, 271:20879-20884.
52. Pini A., Shemesh R., Samuel C.S., Bathgate R.A., Zauberman A., Hermesh C., Wool A., Bani D., Rotman G. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. J. Pharmacol. Exp. Ther. 2010, 335:589-599.
53. Postma D.S., Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006, 3:434-439.
54. Prenner B.M. Asthma 2008: targeting immunoglobulin E to achieve disease control. J. Asthma 2008, 45:429-436.
55. Redington A.E., Madden J., Frew A.J., Djukanovic R., Roche W.R., Holgate S.T., Howarth P.H. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 1997, 156:642-647.
56. Reinhard C., Meyer B., Fuchs H., Stoeger T., Eder G., Ruschendorf F., Heyder J., Nurnberg P., de Angelis M.H., Schulz H. Genomewide linkage analysis identifies novel genetic loci for lung function in mice. Am. J. Respir. Crit. Care Med. 2005, 171:880-888.
57. Royce S.G., Miao Y.R., Lee M., Samuel C.S., Tregear G.W., Tang M.L. Relaxin reverses airway remodeling and airway dysfunction in allergic airways disease. Endocrinology 2009, 150:2692-2699.
58. Sagara H., Okada T., Okumura K., Ogawa H., Ra C., Fukuda T., Nakao A. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J. Allergy Clin. Immunol. 2002, 110:249-254.
59. Saglani S., Malmstrom K., Pelkonen A.S., Malmberg L.P., Lindahl H., Kajosaari M., Turpeinen M., Rogers A.V., Payne D.N., Bush A., Haahtela T., Makela M.J., Jeffery P.K. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am. J. Respir. Crit. Care Med. 2005, 171:722-727.
60. Samuel C.S. Relaxin: antifibrotic properties and effects in models of disease. Clin. Med. Res. 2005, 3:241-249.
61. Samuel C.S., Hewitson T.D. Relaxin in cardiovascular and renal disease. Kidney Int. 2006, 69:1498-1502.
62. Samuel C.S., Zhao C., Bathgate R.A.D., Bond C.P., Burton M.D., Parry L.J., Summers R.J., Tang M.L.K., Amento E.P., Tregear G.W. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J. 2003, 17:121-123.
63. Samuel C.S., Zhao C., Bathgate R.A.D., Du X.-J., Summers R.J., Amento E.P., Walker L.L., McBurnie M., Zhao L., Tregear G.W. The relaxin gene-knockout mouse: a model of progressive fibrosis. Ann. NY Acad. Sci. 2005, 1041:173-181.
64. Samuel C.S., Du X.-J., Bathgate R.A.D., Summers R.J. 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease. Pharmacol. Ther. 2006, 112:529-552.
65. Samuel C.S., Hewitson T.D., Unemori E.N., Tang M.L. Drugs of the future: the hormone relaxin. Cell. Mol. Life Sci. 2007, 64:1539-1557.
66. Samuel C.S., Royce S.G., Chen B., Cao H., Gossen J.A., Tregear G.W., Tang M.L. RXFP1 protects against airway fibrosis during homeostasis, but not against fibrosis associated with chronic allergic airways disease. Endocrinology 2008, 150:1495-1502.
67. Seibold J.R., Clements P.J., Furst D.E., Mayes M.D., McCloskey D.A., Moreland L.W., White B., Wigley F.M., Rocco S., Erikson M., Hannigan J.F., Sanders M.E., Amento E.P. Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis. J. Rheumatol. 1998, 25:302-307.
68. Seibold J.R., Korn J.H., Simms R., Clements P.J., Moreland L.W., Mayes M.D., Furst D.E., Rothfield N., Steen V., Weisman M., Collier D., Wigley F.M., Merkel P.A., Csuka M.E., Hsu V., Rocco S., Erikson M., Hannigan J., Harkonen W.S., Sanders M.E. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2000, 132:871-879.
69. Sherwood O.D. Relaxin's physiological roles and other diverse actions. Endocr. Rev. 2004, 25:205-234.
70. Sobande P.O., Kercsmar C.M. Inhaled corticosteroids in asthma management. Respir. Care 2008, 53:625-633. (discussion 633-4).
71. Szefler S.J., Leung D.Y. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur. Respir. J. 1997, 10:1640-1647.
72. Wenzel S.E., Balzar S., Cundall M., Chu H.W. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J. Allergy Clin. Immunol. 2003, 111:1345-1352.
73. Williams E.J., Benyon R.C., Trim N., Hadwin R., Grove B.H., Arthur M.J., Unemori E.N., Iredale J.P. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 2001, 49:577-583.
74. Yao P.M., Delclaux C., d'Ortho M.P., Maitre B., Harf A., Lafuma C. Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 1998, 18:813-822.